| Experimental group (n = 55) | Control group (n = 34) | For delta indicators | |||||
---|---|---|---|---|---|---|---|---|
Before intervention t−1 | After intervention t0 | Delta changes | Before intervention t−1 | After intervention t0 | Delta changes | t | P | |
UA (μmol/L) | 361.96 ± 96.55 | 357.56 ± 103.13 | −9.75 ± 19.68 | 322.12 ± 90.45 | 307.96 ± 91.46 | −1.31 ± 12.37 | 2.239 | 0.028 |
TC (mmol/L) | 4.52 ± 0.71 | 4.40 ± 0.72 | −0.11 ± 0.40 | 4.76 ± 0.81 | 4.95 ± 0.92 | −0.11 ± 0.59 | 2.953 | 0.004 |
TG (mmol/L) | 1.37 ± 0.65 | 1.31 ± 0.67 | −0.07 ± 0.64 | 1.57 ± 1.42 | 1.47 ± 1.15 | −0.11 ± 0.59 | −0.319 | 0.750 |
LDL-C (mmol/L) | 1.20 ± 0.19 | 1.23 ± 0.21 | 0.02 ± 0.13 | 1.29 ± 0.21 | 1.32 ± 0.24 | 0.04 ± 0.23 | 0.308 | 0.705 |
HDL-C (mmol/L) | 2.77 ± 0.67 | 2.79 ± 0.68 | 0.03 ± 0.39 | 2.87 ± 0.66 | 3.01 ± 0.72 | 0.14 ± 0.40 | 1.286 | 0.202 |
HbA1c (%) | 5.60 ± 0.45 | 5.63 ± 0.45 | 0.03 ± 0.37 | 5.58 ± 0.38 | 5.49 ± 0.36 | −0.09 ± 0.26 | −1.701 | 0.092 |
FBG (mmol/L) | 5.21 ± 0.62 | 4.92 ± 0.5 | −0.28 ± 0.52 | 5.07 ± 0.47 | 4.94 ± 0.74 | −0.13 ± 0.69 | 1.229 | 0.222 |
FI (μU/mL) | 11.16 ± 5.34 | 8.80 ± 5.60 | −2.36 ± 5.20 | 11.45 ± 5.52 | 12.67 ± 7.59 | 1.22 ± 7.34 | 2.688 | 0.009 |
HOMA-IR | 2.59 ± 1.40 | 1.97 ± 1.33 | −0.62 ± 1.25 | 2.58 ± 1.25 | 2.72 ± 1.61 | 0.14 ± 1.83 | 2.327 | 0.022 |